12.07.2015 Views

Accessible Infusion Pump User-Interface - Biomedical Engineering ...

Accessible Infusion Pump User-Interface - Biomedical Engineering ...

Accessible Infusion Pump User-Interface - Biomedical Engineering ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

through all necessary steps before allowing infusion to start. In turn, the impacton patients will be positive by greatly reducing human error and risk of patientdeath.Alaris® Products have gone through detrimental drawbacks due to their faultyinfusion pumps and lack of following the FDA’s medical device manufacturingregulations in. The FDA seized Alaris Signature Edition Gold infusion pumps,model numbers 7130, 7131, 7230, and 7231 (in August 25, 2006), manufacturedby Cardinal Health Care 303, Inc. The design defect found in these models werecalled key bouncing causing over-infusion since the buttons pressed on thepump are registered twice although the user pressed the key once. Since Alarisdistributed their products globally, the seizure of the devices valued Alaris morethan an estimated $1.8 million. If produced and implemented earlier, the finaldesign would have saved Alaris from their 1.8 million dollar loss and preventingtheir loss of credibility within the media and economic market. If implemented,the device’s impact on Alaris can redeem their credibility in the future since theuser-interface does not experience such key bouncing flaws. Nonetheless,before initiating the infusion, the interface will verify the values through the LCDdisplay. As a temporary solution, Alaris recommended steps in minimizing keyentry errors by requesting an independent double check of pump settings byanother practitioner before starting infusion. By observing these steps, thepatients’ independence and privacy is greatly hindered, whereas the finalinfusion pump user-interface will counter act this feature and increase thepatient’s independence.Despite the positive results for corporations, the most important impact of theoptimal design is on the patients themselves. The <strong>Accessible</strong> <strong>Infusion</strong> <strong>Pump</strong><strong>Interface</strong> will allow patients to not only save money, but to regain some of thefreedom claimed by their illness. The accessible nature of the interface will allowpeople who formerly could not reliably operate their own pump to live selfsufficiently. This has a great impact on how a person feels about themselves. Inthe end, the perception of what the limitations on the elderly and ill are couldchange on a societal level allowing the patients to regain any lost dignity.The success of some medical infusion pump companies, such as B. BraunMedical and Curlin Medical, is the expected impact of our final user-interfacedevice after implementation in biomedical infusion pump companies. Thepartnership between the companies has provided “the most dependableinfusion pumps featuring breakthrough safety technology and industry-leadingexpertise”, leading to their “strong growth in market shares and units”. As aresult, the market conditions “created an environment for significant marketgrowth and adoption in hospital and outpatient settings”, providing the“medical community with the highest level of supply and service support,training and technical support”. As a result, the impact of our final user-interfacewill have similar to those found between B. Braun Medical and Curlin Medical.102

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!